Halodoc
Indonesian app linking patients to licensed doctors and 4,900+ partner pharmacies.
On the record
Checkpoint: Whether Halodoc announces a fresh primary funding round or IPO filing
The call
Halodoc's medical licensing and pharmacy network keep AI chatbots and app rivals out, while Astra's growing stake quietly reshapes who owns the win.
Halodoc lets Indonesian patients talk to real doctors online and get prescriptions filled through partner pharmacies. Generic AI chatbots like ChatGPT can handle basic health questions, but they cannot legally prescribe medicine or navigate Indonesia's medical rules the way Halodoc's 20,000 licensed doctors can. The big question is whether Halodoc stays independent or gets absorbed by Astra International, the conglomerate that has been quietly buying more of the company (from 21% to 31% ownership in early 2025). If Astra buys the rest outright instead of letting Halodoc raise new funding on its own, early investors' shares could become worth much less or stuck in a private company for years.
Why
01
AI pressure: Generic AI chatbots like ChatGPT and Doctronic. Free AI symptom checkers can copy Halodoc's chat triage but cannot prescribe, dispense, or bill Indonesian insurers. Could AI do the core job? Unlikely.
02
Bigger players: Astra International. Astra raised its stake from 21% to 31.34% in Feb 2025, pointing toward absorption rather than a rival stealing customers. Could a giant copy it? Probably.
03
What protects it. Licensed doctor network, pharmacy delivery logistics, and Indonesian medical-regulatory approvals AI and rivals can't copy overnight.
What would change this call
Astra International's stake in Halodoc rises above the current 31.34 percent. Would show movement toward Astra absorbing Halodoc rather than it staying independently owned.
No new primary funding round or IPO filing is announced by end of 2026. Would confirm the three-year funding silence reflects a buyout path, not a growth pause.
Halodoc headcount falls further below the post-2023-layoff level. Would indicate continued contraction rather than renewed scaling.
No new primary funding round or IPO filing is announced by end of 2026. Would confirm the three-year funding silence reflects a buyout path, not a growth pause.
Halodoc headcount falls further below the post-2023-layoff level. Would indicate continued contraction rather than renewed scaling.
Key numbers
- 20+ million monthly active users
- 20,000+ licensed doctors on platform
- Astra stake rose to 31.34%
Named risks
- No new primary funding round since July 2023 Series D, three years of capital silence.
- Astra International's rising stake (21% to 31.34% by Feb 2025) signals possible conglomerate absorption over independent scaling.
- Headcount fell from ~1,600 (Feb 2023) to ~1,399 (Nov 2024) after Nov 2023 layoffs, only modest 1% YoY recovery by Jul 2026.
- No audited revenue disclosed, third party revenue estimates wildly inconsistent, unit economics unverifiable.
- Generic AI chat tools could commoditize the low acuity triage layer of teleconsultation funnel.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Good Doctor Technology (Grab affiliated) | gaining on | Rival reportedly acquired by WhiteCoat around Mar 2026, reducing Grab's telehealth presence in Indonesia |
| Alodokter | contesting | Alodokter raised only $5.2M in its Feb 2024 Series D versus Halodoc's $100M Series D in Jul 2023 |
| Generic AI chatbots (ChatGPT, Doctronic) | contesting | Can commoditize symptom triage chat but lack licensed prescribing and Indonesian regulatory compliance |
| KlikDokter, HonestDocs, ProSehat | contesting | Smaller local Indonesian telehealth apps competing for share of teleconsultation market |
Questions people ask
- Is Halodoc profitable in 2026?
- Halodoc has never disclosed audited revenue or profit figures. As a private company with its last funding round in July 2023 ($100M Series D led by Astra Digital Internasional), no confirmed profitability data exists as of mid 2026, leaving its unit economics unverified.
- Did Halodoc lay off employees?
- Yes. Halodoc announced layoffs in November 2023, described by the company as improving productivity, when it had roughly 1,500 staff. Headcount fell from about 1,600 in February 2023 to about 1,399 by November 2024, per Crustdata tracking.
- Could AI replace Halodoc?
- Unlikely to fully replace it. Generic AI chatbots like ChatGPT or Doctronic can commoditize low acuity symptom triage, but Halodoc's licensed 20,000+ doctor network, 4,900+ pharmacy delivery logistics, and Indonesian medical licensing (per McKinsey, Feb 2025) are not AI replicable.
- Who owns Halodoc?
- Halodoc is privately held and venture backed, founded by Jonathan Sudharta in April 2016. PT Astra International, an Indonesian conglomerate, is the largest known strategic shareholder, raising its stake from 21% to 31.34% in February 2025 via a roughly $55-57M transaction.
- Is Halodoc a safe company to join in 2026?
- Mixed signal. Headcount grew only about 1% year over year to roughly 1,423 employees by July 2026 after November 2023 layoffs, and the company has raised no new funding since its July 2023 Series D, though its business model shows no signs of near-term collapse.
- Who is Halodoc's biggest competitor?
- Domestically, Alodokter and Good Doctor Technology (Grab affiliated) are closest peers. Good Doctor was reportedly being acquired by Singapore's WhiteCoat around March 2026, signaling consolidation pressure among smaller Indonesian telehealth rivals versus Halodoc's scale.
Timeline
- 2026-03-20Good Doctor Technology (Grab affiliated) reportedly subject to acquisition by WhiteCoat
- 2025-02-04McKinsey interview cites 20,000+ licensed healthcare professionals on Halodoc
- 2025-02Astra International raises Halodoc stake from 21% to 31.34% via ~$55-57M deal
- 2023-11Halodoc announces layoffs for productivity, staff around 1,500 at the time
- 2023-10-15Halodoc announces IVD joint venture with Fapon
- 2023-07Series D raises $100M led by Astra Digital Internasional
- 2023-05-04AWS press release reports 20M+ MAU and 4,900+ partner pharmacies
- 2021-04Series C raises $80M led by PT Astra International
- 2019-03Series B raises $65M led by UOB Venture
- 2016-04Halodoc founded by Jonathan Sudharta in Jakarta
Revision history
30 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Halodoc Brings Holistic Healthcare to More than 20 Million Indonesian Users using AWS (2023-05-04)
- Connecting patients to healthcare: A conversation with Halodoc's Jonathan Sudharta (2025-02-04)
- Bill Gates and Former Bass Guitarist Aim to Change Health Care (2019-07-25)
- Astra Leads Series D for Indonesia's Halodoc (2023-07-31)
- Halodoc - Headcount, Funding & Open Jobs (2026-07-21)
- Valuation, Funding Rounds & Stock Price (2025-10-07)
- Astra International (ASII) Sharpens Focus on the Health Sector (2025-03-03)
- Healthtech Firm Halodoc Lays Off Employees Despite Recent Funding (2025-04-14)
- AI-Powered Testcase Generation with PRD & UI (2025-05-22)
- Halodoc Blog (2026-07-24)
- Valuation, Funding Rounds & Stock Price (2026-03-20)
- Valuation, Funding Rounds & Stock Price (2025-09-17)